{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T17:31:46Z","timestamp":1771954306135,"version":"3.50.1"},"reference-count":63,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,22]],"date-time":"2013-07-22T00:00:00Z","timestamp":1374451200000},"content-version":"vor","delay-in-days":721,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1016\/j.pnpbp.2011.06.002","type":"journal-article","created":{"date-parts":[[2011,6,24]],"date-time":"2011-06-24T19:01:51Z","timestamp":1308942111000},"page":"1636-1644","source":"Crossref","is-referenced-by-count":59,"title":["Myricitrin, a nitric oxide and protein kinase C inhibitor, exerts antipsychotic-like effects in animal models"],"prefix":"10.1016","volume":"35","author":[{"given":"M.","family":"Pereira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.P.","family":"Siba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.R.","family":"Chioca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Correia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.A.B.F.","family":"Vital","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.G.","family":"Pizzolatti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.R.S.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Andreatini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2011.06.002_bb0005","article-title":"Carbon-13 NMR of flavonoids","volume":"vol. 39","author":"Agrawal","year":"1989"},{"key":"10.1016\/j.pnpbp.2011.06.002_bb0010","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1038\/sj.npp.1301242","article-title":"Striatal vs extrastriatal dopamine D2 receptors in antipsychotic response: a double-blind PET study in schizophrenia","volume":"32","author":"Agid","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2011.06.002_bb0015","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1001\/archpsyc.1993.01820150007001","article-title":"Altered distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase cells in frontal lobe of schizophrenics implies disturbances of cortical development","volume":"50","author":"Akbarian","year":"1993","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.06.002_bb0020","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1001\/archpsyc.1993.01820150016002","article-title":"Distorted distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase neurons in temporal lobe of schizophrenics implies anomalous cortical development","volume":"50","author":"Akbarian","year":"1993","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.06.002_bb0025","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00210-006-0092-z","article-title":"In vivo occupancy of dopamine D2 receptors by antipsychotic drugs and novel compounds in the mouse striatum and olfactory tubercles","volume":"373","author":"Assi\u00e9","year":"2006","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.pnpbp.2011.06.002_bb0030","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/sj.npp.1300940","article-title":"Antipsychotic-like vs cataleptogenic actions in mice of novel antipsychotics having D2 antagonist and 5-HT1A agonist properties","volume":"31","author":"Bardin","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2011.06.002_bb0035","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0166-4328(01)00165-6","article-title":"Nitric oxide involvement in the anxiogenic-like effect of substance P","volume":"121","author":"Baretta","year":"2001","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pnpbp.2011.06.002_bb0040","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1001\/archpsyc.57.1.95","article-title":"A preliminary investigation of a protein kinase C inhibitor in the treatment of acute mania","volume":"57","author":"Bebchuk","year":"2000","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.06.002_bb0045","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.schres.2005.05.019","article-title":"The many faces of nitric oxide in schizophrenia: a review","volume":"78","author":"Bernstein","year":"2005","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pnpbp.2011.06.002_bb0050","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0741-8329(95)00002-9","article-title":"Prolonged treatment with carbamazepine increases the stimulatory effects of ethanol in mice","volume":"12","author":"Camarini","year":"1995","journal-title":"Alcohol"},{"key":"10.1016\/j.pnpbp.2011.06.002_bb0055","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/S0006-2952(00)00255-0","article-title":"Oroxylin A inhibition of lipopolysaccharide-induced iNOS and COX-2 gene expression via suppression of nuclear factor-\u03baB activation","volume":"59","author":"Chen","year":"2000","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pnpbp.2011.06.002_bb0060","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/sj.npp.1300789","article-title":"Characterization of the rapid-onset type of behavioral sensitization to amphetamine in mice: role of drug-environment conditioning","volume":"31","author":"Chinen","year":"2006","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.pnpbp.2011.06.002_bb0065","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0014-2999(78)90251-0","article-title":"Climbing behaviour induced by apomorphine in mice: a potential model for the detection of neuroleptic activity","volume":"50","author":"Costall","year":"1978","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pnpbp.2011.06.002_bb0070","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/BF02245859","article-title":"The olfactory tubercle as a site of action of neuroleptics with an atypical profile in the paw test: effect of risperidone, prothipendyl, ORG 5222, sertindole and olanzapine","volume":"119","author":"Cools","year":"1995","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2011.06.002_bb0075","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0306-3623(97)00075-X","article-title":"Catalepsy induced by nitric oxide inhibitors","volume":"30","author":"Del Bel","year":"1998","journal-title":"Gen Pharmacol"},{"key":"10.1016\/j.pnpbp.2011.06.002_bb0080","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s002130050003","article-title":"Sub-chronic inhibition of nitric-oxide synthesis modifies haloperidol-induced catalepsy and the number of NADPH-diaphorase neurons in mice","volume":"147","author":"Del Bel","year":"2000","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2011.06.002_bb0085","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s00213-002-1009-2","article-title":"Motor effects of acute and chronic inhibition of nitric oxide synthesis in mice","volume":"161","author":"Del Bel","year":"2002","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2011.06.002_bb0090","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s10571-005-3065-8","article-title":"Role of nitric oxide on motor behavior","volume":"25","author":"Del Bel","year":"2005","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.pnpbp.2011.06.002_bb0095","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1038\/sj.npp.1300261","article-title":"SSR181507, a dopamine D2 receptor antagonist and 5-HT1A receptor agonist: II. Behavioral profile predictive of an atypical antipsychotic activity","volume":"28","author":"Depoortere","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2011.06.002_bb0100","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/00002826-199708000-00008","article-title":"Methylene blue adjuvant therapy of schizophrenia","volume":"20","author":"Deutsch","year":"1997","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.pnpbp.2011.06.002_bb0105","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s11920-008-0081-7","article-title":"A review of the preclinical and clinical evidence for protein kinase C as a target for drug development for bipolar disorder","volume":"10","author":"DiazGranados","year":"2008","journal-title":"Curr Psychiatry Rep"},{"key":"10.1016\/j.pnpbp.2011.06.002_bb0110","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S0022-3565(24)35156-0","article-title":"Effects of treatment with haloperidol, chlorpromazine, and clozapine on protein kinase C (PKC) and phosphoinositide-specific phospholipase C (PI-PLC) activity and on mRNA and protein expression of PKC and PLC isozymes in rat brain","volume":"291","author":"Dwivedi","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pnpbp.2011.06.002_bb0115","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00213-007-0834-8","article-title":"Intracerebroventricular administration of nitric oxide-sensitive guanylyl cyclase inhibitors induces catalepsy in mice","volume":"194","author":"Echeverry","year":"2007","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2011.06.002_bb0120","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000106054","article-title":"Protein kinase C inhibition by tamoxifen antagonizes manic-like behavior in rats: implications for the development of novel therapeutics for bipolar disorder","volume":"55","author":"Einat","year":"2007","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.pnpbp.2011.06.002_bb0125","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/BF00187254","article-title":"The paw test: a behavioural paradigm for differentiating between classical and atypical neuroleptic drugs","volume":"93","author":"Ellenbroek","year":"1987","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2011.06.002_bb0130","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/0024-3205(88)90551-6","article-title":"The paw test: an animal model for neuroleptic drugs which fulfils the criteria for pharmacological isomorphism","volume":"42","author":"Ellenbroek","year":"1988","journal-title":"Life Sci"},{"key":"10.1016\/j.pnpbp.2011.06.002_bb0135","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/0893-133X(96)00001-2","article-title":"Activity of \u201cseroquel\u201d (ICI 204,636) in animal models for atypical properties of antipsychotics: a comparison with clozapine","volume":"15","author":"Ellenbroek","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2011.06.002_bb0140","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S0022-3565(24)29392-7","article-title":"Effects of JL13, a pyridobenzoxazepine with potential atypical antipsychotic activity, in animal models for schizophrenia","volume":"298","author":"Ellenbroek","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pnpbp.2011.06.002_bb0145","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1007\/s11064-009-9969-9","article-title":"The flavonoid glycosides, myricitriin, gossypin and narigin exert anxiolytic action in mice","volume":"34","author":"Fernandez","year":"2009","journal-title":"Neurochem Res"},{"key":"10.1016\/j.pnpbp.2011.06.002_bb0150","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0361-9230(96)00035-4","article-title":"Association of dopaminergic terminals and neurons releasing nitric oxide in the rat striatum: an electron microscopic study using NADPH-diaphorase histochemistry and tyrosine hydroxylase immunohistochemistry","volume":"40","author":"Fujiyama","year":"1996","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.pnpbp.2011.06.002_bb0155","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.pnpbp.2003.09.003","article-title":"Animal behavior models of the mechanisms underlying antipsychotic atypicality","volume":"27","author":"Geyer","year":"2003","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.06.002_bb0160","series-title":"Manic-depressive illness: bipolar disorders and recurrent depression","author":"Goodwin","year":"2007"},{"key":"10.1016\/j.pnpbp.2011.06.002_bb0165","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.bbr.2009.08.003","article-title":"Nitric oxide modulation of methylphenidate-induced disruption of prepulse inhibition in Swiss mice","volume":"205","author":"Issy","year":"2009","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pnpbp.2011.06.002_bb0170","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.phrs.2005.05.002","article-title":"The role of nitric oxide on glutaminergic modulation of dopaminergic activation","volume":"52","author":"Hong","year":"2005","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.pnpbp.2011.06.002_bb0175","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.psyneuen.2005.11.001","article-title":"A pilot estudy of hormone modulation as a new treatment for mania in women with bipolar affective disorder","volume":"31","author":"Kulkarni","year":"2006","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pnpbp.2011.06.002_bb0180","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0160-5402(86)90038-0","article-title":"Intracerebroventricular injections in mice: some methodological refinements","volume":"16","author":"Laursen","year":"1986","journal-title":"J Pharmacol Methods"},{"key":"10.1016\/j.pnpbp.2011.06.002_bb0185","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ejphar.2007.09.016","article-title":"Aripiprazole, an atypical antipsychotic, prevents the motor hyperactivity induced by psychotomimetics and psychostimulants in mice","volume":"578","author":"Leite","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pnpbp.2011.06.002_bb0190","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/S0006-3223(99)00235-8","article-title":"Protein kinase C signaling in the brain: molecular transduction of mood stabilization in the treatment of manic-depressive illness","volume":"46","author":"Manji","year":"1999","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.06.002_bb0195","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/BF00431856","article-title":"A gradual score to evaluate the climbing behaviour elicited by apomorphine in mice","volume":"56","author":"Marcais","year":"1978","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2011.06.002_bb0200","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/00001756-199512000-00038","article-title":"L-NOARG, an inhibitor of nitric oxide synthase, induces catalepsy in mice","volume":"7","author":"Marras","year":"1995","journal-title":"Neuroreport"},{"key":"10.1016\/j.pnpbp.2011.06.002_bb0205","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1124\/jpet.105.092825","article-title":"Analysis of the antinociceptive effect of the flavonoid myricitrin: evidence for a role of the L-arginine-nitric oxide and protein kinase C pathways","volume":"316","author":"Meotti","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pnpbp.2011.06.002_bb0210","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/j.bcp.2006.08.028","article-title":"Anti-allodynic property of flavonoid myricitrin in models of persistent inflammatory and neuropathic pain in mice","volume":"72","author":"Meotti","year":"2006","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pnpbp.2011.06.002_bb0215","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.bcp.2007.06.024","article-title":"Involvement of p38MAPK on the antinociceptive action of myricitrin in mice","volume":"74","author":"Meotti","year":"2007","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pnpbp.2011.06.002_bb0220","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ejphar.2007.03.039","article-title":"Antinociceptive action of myricitrin: involvement of the K+ and Ca2+ channels","volume":"567","author":"Meotti","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pnpbp.2011.06.002_bb0225","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s10517-005-0285-3","article-title":"Modulating role of NO in haloperidol-induced catalepsy","volume":"139","author":"Narkevich","year":"2005","journal-title":"Bull Exp Biol Med"},{"key":"10.1016\/j.pnpbp.2011.06.002_bb0230","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1002\/syn.20835","article-title":"Neonatal ventral hippocampus lesion induces increase in NO levels which is attenuated by subchronic haloperidol treatment","volume":"64","author":"Negrete-D\u00edaz","year":"2010","journal-title":"Synapse"},{"key":"10.1016\/j.pnpbp.2011.06.002_bb0235","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.euroneuro.2009.03.003","article-title":"Tolerability of outpatient antipsychotic treatment: 36-month results from the European Schizophrenia Outpatient Health Outcomes (SOHO) study","volume":"19","author":"Novick","year":"2009","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pnpbp.2011.06.002_bb0240","first-page":"1045","article-title":"Effects of losartan on neuroleptic-induced catalepsy in mice","volume":"29","author":"Pires","year":"1996","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.pnpbp.2011.06.002_bb0245","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1590\/S0100-879X2003000200012","article-title":"Gender-related differences in the effects of nitric oxide donors on neuroleptic-induced catalepsy in mice","volume":"36","author":"Pires","year":"2003","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.pnpbp.2011.06.002_bb0250","series-title":"Methods in Behavioral Pharmacology","first-page":"23","article-title":"Psychotropic screening procedures","author":"Porsolt","year":"1993"},{"key":"10.1016\/j.pnpbp.2011.06.002_bb0255","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1124\/jpet.110.166710","article-title":"Behavioral indices in antipsychotic drug discovery","volume":"333","author":"Porsolt","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pnpbp.2011.06.002_bb0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00634146","article-title":"Climbing behavior induced by apomorphine in mice: a simple test for the study of dopamine receptors in striatum","volume":"50","author":"Protais","year":"1976","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2011.06.002_bb0265","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1016\/j.pnpbp.2008.09.023","article-title":"The antimanic-like effect of tamoxifen: behavioural comparison with other PKC-inhibiting and antiestrogenic drugs","volume":"32","author":"Sabioni","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"2","key":"10.1016\/j.pnpbp.2011.06.002_bb0270","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00213-005-0277-z","article-title":"Dopamine and nitric oxide interaction on the modulation of prepulse inhibition of the acoustic startle response in the Wistar rat","volume":"185","author":"Salum","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pnpbp.2011.06.002_bb0275","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.brainres.2007.12.054","article-title":"Modulation of dopamine uptake by nitric oxide in cultured mesencephalic neurons","volume":"1198","author":"Salum","year":"2008","journal-title":"Brain Res"},{"key":"10.1016\/j.pnpbp.2011.06.002_bb0280","doi-asserted-by":"crossref","unstructured":"Serretti A, Chiesa A. A meta-analysis of sexual dysfunction in psychiatric patients taking antipsychotics. Int. Clin. Psychopharmacol. Int Clin Psychopharmacol 2011;26(3):130\u201340.","DOI":"10.1097\/YIC.0b013e328341e434"},{"key":"10.1016\/j.pnpbp.2011.06.002_bb0285","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0014-2999(94)00644-M","article-title":"Do NMDA receptor-mediated changes in motor behaviour involve nitric oxide?","volume":"272","author":"Starr","year":"1995","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pnpbp.2011.06.002_bb0290","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1177\/0269881109106959","article-title":"The biological basis of antipsychotic response in schizophrenia","volume":"24","author":"Stone","year":"2010","journal-title":"J Psychopharmacol"},{"issue":"1\u20133","key":"10.1016\/j.pnpbp.2011.06.002_bb0295","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.schres.2007.11.033","article-title":"World Psychiatric Association Pharmacopsychiatry Section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia","volume":"100","author":"Tandon","year":"2008","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pnpbp.2011.06.002_bb0300","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/syn.10076","article-title":"Regulation of striatal dopamine neurotransmission by nitric oxide: effector pathways and signaling mechanisms","volume":"44","author":"West","year":"2002","journal-title":"Synapse"},{"key":"10.1016\/j.pnpbp.2011.06.002_bb0305","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0893-133X(98)00008-6","article-title":"Nitric oxide synthase inhibitors attenuate phencyclidine-induced disruption of prepulse inhibition","volume":"19","author":"Wiley","year":"1998","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2011.06.002_bb0310","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1001\/archgenpsychiatry.2007.43","article-title":"Protein kinase C inhibition in the treatment of mania: a double blind, placebo-controlled trial of tamoxifen","volume":"65","author":"Yildiz","year":"2008","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.06.002_bb0315","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1399-5618.2007.00530.x","article-title":"Efficacy of a protein kinase C inhibitor (tamoxifen) in the treatment of acute mania: a pilot study","volume":"9","author":"Zarate","year":"2007","journal-title":"Bipolar Disord"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584611001928?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584611001928?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T16:16:36Z","timestamp":1741277796000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584611001928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":63,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S0278584611001928"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2011.06.002","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}